Napp and colleagues reported clinical courses of 16 patients who received Impella percutaneous left ventricular assist device (LVAD) supports for Takotsubo syndrome with cardiogenic shock . Mortality was low and left ventricular systolic function recovered in all survivors. Several concerns have been raised.